Tilray Brands, Inc. (2HQ.DE)

EUR 1.16

(0.43%)

Operating Expenses Summary of Tilray Brands, Inc.

  • Tilray Brands, Inc.'s latest annual operating expenses in 2023 was 410.32 Million USD , up 37.85% from previous year.
  • Tilray Brands, Inc.'s latest quarterly operating expenses in 2024 Q1 was 89.3 Million USD , down -9.49% from previous quarter.
  • Tilray Brands, Inc. reported a annual operating expenses of 325.1 Million USD in annual operating expenses 2022, down -5.87% from previous year.
  • Tilray Brands, Inc. reported a annual operating expenses of 345.37 Million USD in annual operating expenses 2021, up 80.12% from previous year.
  • Tilray Brands, Inc. reported a quarterly operating expenses of 78.21 Million USD for 2023 Q1, down -9.49% from previous quarter.
  • Tilray Brands, Inc. reported a quarterly operating expenses of 116.07 Million USD for 2023 Q4, up 40.24% from previous quarter.

Annual Operating Expenses Chart of Tilray Brands, Inc. (2023 - 2011)

Historical Annual Operating Expenses of Tilray Brands, Inc. (2023 - 2011)

Year Operating Expenses Operating Expenses Growth
2023 410.32 Million USD 37.85%
2022 325.1 Million USD -5.87%
2021 345.37 Million USD 80.12%
2020 191.74 Million USD 41.24%
2019 135.75 Million CAD 31.88%
2018 102.94 Million CAD 175.83%
2017 37.31 Million CAD 231.0%
2016 11.27 Million CAD 108.06%
2015 5.41 Million CAD -9.82%
2014 6 Million CAD 540.75%
2013 937.88 Thousand USD 1968.69%
2012 45.33 Thousand CAD -53.98%
2011 98.51 Thousand CAD 0.0%

Peer Operating Expenses Comparison of Tilray Brands, Inc.

Name Operating Expenses Operating Expenses Difference
MPH Health Care AG 4.22 Million EUR -9619.735%
Apontis Pharma AG 23.17 Million EUR -1670.897%
Dermapharm Holding SE 142.51 Million EUR -187.92%
Evotec SE 222.55 Million EUR -84.368%
MERCK Kommanditgesellschaft auf Aktien 8.82 Billion EUR 95.351%
PharmaSGP Holding SE 50.72 Million EUR -708.955%
SynBiotic SE 1.5 Million EUR -27138.522%